| 发明名称 |
ORAL PHARMACEUTICAL COMPOSITION |
| 摘要 |
The present invention provides an FTD and TPI-containing oral pharmaceutical composition which can be orally administered and is stable even under high humidity conditions.;An oral pharmaceutical composition comprising α,α,α-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl)methyl-2,4(1H,3H)-pyrimidine dione hydrochloride as an active ingredient; and being substantially free of an additive comprising a metal salt. |
| 申请公布号 |
US2014363512(A1) |
申请公布日期 |
2014.12.11 |
| 申请号 |
US201314373449 |
申请日期 |
2013.02.14 |
| 申请人 |
TAIHO PHARMACEUTICAL CO., LTD. |
发明人 |
Ohnishi Yoshito;Ogata Tetsuo |
| 分类号 |
A61K9/00;A61K31/513;A61K31/7072 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An oral pharmaceutical composition comprising α,α,α-trifluorothymidine and 5-chloro-6-(2-iminopyrrolidine-1-yl)methyl-2,4(1H,3H)-pyrimidine dione hydrochloride as an active ingredient; and being substantially free of an additive comprising a metal salt. |
| 地址 |
Chiyoda-ku JP |
